Amarin | AMRN - Activos Circulantes





Activos Circulantes Cambio Fecha
AbbVie USD 33.53B 4.47B 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amarin USD 626.02M 23.87M 2026-03
AstraZeneca USD 29.61B 890M 2026-03
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
DBV Technologies USD 212.94M 124.06M 2025-12
Esperion Therapeutics USD 459.46M 3.11M 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Halozyme Therapeutics USD 1B 177.83M 2026-03
Heron Therapeutics USD 228.98M 9.08M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Novartis USD 26.61B 3.85B 2026-03